Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease

[1]  E. Hirsch,et al.  Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease , 2020, Movement disorders : official journal of the Movement Disorder Society.

[2]  Amit A. Patel,et al.  Inherited and Environmental Factors Influence Human Monocyte Heterogeneity , 2019, Front. Immunol..

[3]  Han-Joon Kim,et al.  Peripheral Blood Inflammatory Cytokines in Idiopathic REM Sleep Behavior Disorder , 2019, Movement disorders : official journal of the Movement Disorder Society.

[4]  Alan J. Thomas,et al.  Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease , 2019, International journal of geriatric psychiatry.

[5]  Wei Yang,et al.  Deficiency of Socs3 leads to brain-targeted EAE via enhanced neutrophil activation and ROS production. , 2019, JCI insight.

[6]  G. Casimir,et al.  Editorial: Sexual Dimorphism of the Immune Inflammatory Response in Infectious and Non-infectious Diseases , 2019, Front. Immunol..

[7]  D. Standaert,et al.  Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease , 2018, Journal of Neuroinflammation.

[8]  Wei Yang,et al.  CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1 , 2018, The Journal of Immunology.

[9]  D. Standaert,et al.  Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease , 2018, Experimental Neurology.

[10]  S. Mallal,et al.  T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.

[11]  Wei Yang,et al.  Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation , 2017, The Journal of Immunology.

[12]  M. Colonna,et al.  Microglia Function in the Central Nervous System During Health and Neurodegeneration. , 2017, Annual review of immunology.

[13]  Marco Prinz,et al.  The role of peripheral immune cells in the CNS in steady state and disease , 2017, Nature Neuroscience.

[14]  Andreas W. Schreiber,et al.  BAM-matcher: a tool for rapid NGS sample matching , 2016, Bioinform..

[15]  D. Standaert,et al.  Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration , 2016, The Journal of Neuroscience.

[16]  R. Barker,et al.  Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD) , 2016, Movement disorders : official journal of the Movement Disorder Society.

[17]  A. West,et al.  M1 and M2 immune activation in Parkinson’s Disease: Foe and ally? , 2015, Neuroscience.

[18]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[19]  J. Kassubek,et al.  Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients , 2014, Acta Neuropathologica.

[20]  Daphne Koller,et al.  Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.

[21]  Tom C. Freeman,et al.  Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation , 2014, Immunity.

[22]  J. Langston,et al.  Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease , 2013, PloS one.

[23]  Robert Gentleman,et al.  Software for Computing and Annotating Genomic Ranges , 2013, PLoS Comput. Biol..

[24]  D. Standaert,et al.  MHCII Is Required for α-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration , 2013, The Journal of Neuroscience.

[25]  Steffen Jung,et al.  Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. , 2013, Immunity.

[26]  T. Gasser,et al.  Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease , 2013, Movement disorders : official journal of the Movement Disorder Society.

[27]  Jie-zhong Yu,et al.  Targeting the Shift from M1 to M2 Macrophages in Experimental Autoimmune Encephalomyelitis Mice Treated with Fasudil , 2013, PloS one.

[28]  J. Meza,et al.  CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease , 2012, Journal of Neuroimmune Pharmacology.

[29]  W. Oertel,et al.  Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[30]  Steffen Jung,et al.  Infiltrating Blood-Derived Macrophages Are Vital Cells Playing an Anti-inflammatory Role in Recovery from Spinal Cord Injury in Mice , 2009, PLoS medicine.

[31]  E. Hirsch,et al.  Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. , 2008, The Journal of clinical investigation.

[32]  M. Frosch,et al.  Effects of gender on nigral gene expression and parkinson disease , 2007, Neurobiology of Disease.

[33]  Bastiaan R Bloem,et al.  Gender differences in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[34]  K. H. Albrecht,et al.  Supplemental Experimental Procedures cRNA Probe and Radioactive In Situ Hybridization , 2022 .

[35]  D. Schaid,et al.  Validation of a telephone questionnaire for Parkinson's disease. , 1998, Journal of clinical epidemiology.

[36]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[37]  Zachary D. Wallen,et al.  Innate and adaptive immune responses in Parkinson's disease. , 2020, Progress in brain research.

[38]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[39]  T. Nagatsu,et al.  Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. , 1996, Neuroscience letters.